For US Healthcare Professionals
Pediatric VTE and post-Fontan care are complex.1,2
Helping protect against thrombosis doesn’t have to be.
FDA APPROVED with 2 indications in pediatric patients3
XARELTO®: the direct oral anticoagulant (DOAC) studied in the largest clinical trials for pediatric VTE treatment and prevention (N=500) and for pediatric patients post-Fontan procedure (N=110)4-8